Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores
the evidence surrounding community pharmacist interventions to reduce cardiovascular …

The increasing global stroke burden strongly suggests that currently implemented primary
stroke prevention strategies are not sufficiently effective, and new primary prevention …

Background Meeting global health challenges requires effective behaviour change
interventions (BCIs). This depends on advancing the science of behaviour change which, in …

Background: Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …

Introduction Community pharmacies are well placed to deliver education and counseling to
improve sleep health. Objective To develop, implement and evaluate a pharmacist led sleep …

Community pharmacist is one of the most prominent and accessible healthcare professions.
The community pharmacists' role in healthcare is evolving, with opportunities being taken to …

There is ample evidence in the international literature for pharmacist involvement in the
prevention and management of cardiovascular disease (CVD) conditions in primary care …

Adherence to medication is one of the most significant challenges of secondary prevention
in patients after an acute myocardial infarction (AMI). Indeed, it has been well established …

Objective To assess the level of adherence to angiotensin receptor blockers (ARBs) in
patients regularly attending a community pharmacy and the influence of a change in …

The aim of this study was to develop and evaluate a dietary screening tool for use in a
secondary cardiovascular disease (CVD) prevention setting to identify an individual's overall …